Biomarkers Market

Company Headquarters: California, US Founded: 2007 Company Working: Signosis is a molecular tool company that is focused on developing innovative and unique products for biomarker discovery and analysis in the areas of life science research, clinical application, and drug discovery. The company offers a wide selection of validated luciferase reporter cell lines that measure transcription factor activity as a read-out for various signaling pathways in many cell lines and provide a wide spectrum of over-expression stable cell lines, including a series of EGFR mutant over-expression stable cell lines. In addition to that, Signosis provides custom services in making custom assay kits and performing the assay and data analysis, generating custom stable cell lines to facilitate scientists’ research projects. It has distributors all around the world, including Germany, the UK, France, Sweden, Norway, Denmark, Finland, Italy, Australia, Egypt, Israel, Korea, Japan, Taiwan, and China.

Company Headquarters: New York, US Founded: 1976 Workforce: ~460 Company Working: Enzo Biochem Inc. is a life science, and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics, and therapeutics and provides reference laboratory services to the medical community. The company has significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. It operates three wholly-owned subsidiaries, namely, Enzo Life Sciences, Enzo Therapeutics, and Enzo Clinical Labs.

Company Headquarters: Penarth, Cardiff, UK Founded: 1990 Workforce: ~300 Company Working: EKF Diagnostics is a healthcare company. It specializes in the development, manufacture, and distribution of point of care analyzers for hemoglobin, HbA1c, glucose, lactate, as well as a wide range of clinical chemistry products and biomarker-based ELISA and rapid tests. EKF Diagnostics provides its products to more than 100 countries. It is listed on the alternative investment market at the London Stock Exchange

Company Headquarters: Germany, Europe Founded: 1984 Workforce: 5,000 Company Working: Qiagen is a healthcare company that deals in sample and assay technologies for molecular diagnostics. The company operates through more than 35 offices spread in over 25 countries. It serves more than 500,000 customers across the globe. Its product portfolio spans through a full range of molecular testing applications. Qiagen’s products are used for extraction, purification, and stabilization of DNA, RNA, and protein from various biological samples. It has over 500 core products in its portfolio. The company is listed on the New York Stock and Frankfurt Prime Standard exchanges. It offers its products in various areas such as discovery & translational research, diagnostics & clinical research, next-generation sequencing, and instruments & automation.

Company Headquarters: Darmstadt, Germany Founded: 1668 Workforce: ~60,348 Company Working: Merck KGaA (Merck) is a pharmaceutical company that offers a varied range of products subgrouped into three segments—healthcare, life sciences, and performance materials. The company delivers innovative health solutions and is dedicated to providing breakthrough solutions and technologies. The company research drugs in the areas of oncology and neurodegenerative as well as autoimmune and inflammatory diseases. It also markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for industries such as pharmaceuticals, food, cosmetics, packaging, and coatings. It has expanded its global footprint through several mergers and acquisitions, such as the acquisition of Millipore and Sigma-Aldrich. The company is distributing its products in the following countries: China, India, Japan, Australia, Israel, United Arab Emirates, South Korea, Denmark, Italy, Netherlands, Spain, United Kingdom, Switzerland, Sweden, Argentina, Brazil, Canada, US, New Zealand among others.

Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.